Coorough Nicholas E, Schneider David F, Rosen Monica Woll, Sippel Rebecca S, Chen Herbert, Schwarze Margaret L, Mazeh Haggi
Department of Surgery, University of Wisconsin, Madison, WI, USA.
World J Surg. 2014 Mar;38(3):696-703. doi: 10.1007/s00268-013-2405-y.
Transaxillary thyroidectomy (TAT) has gained popularity in East Asian countries; however, to date there have been no attempts to evaluate the preferences regarding TAT in the US population. The aim of this study is to assess the preferences and considerations associated with TAT in an American cohort.
Self-administered surveys were distributed to 966 adults at various locations in a single state. Questions assessed preferences for the surgical approach, acceptable risks and extra costs, and willingness to pursue TAT despite reduced cancer treatment efficacy.
The response rate was 84 %, with a mean age of 40 ± 17 years. The majority of respondents were female. Of the respondents, 82 % preferred TAT to a cervical thyroidectomy (CerT), all risks being equal; 51 % of the respondents were willing to accept a 4 % complication rate with TAT, and 16 % stated they would agree to pay up to an additional $US5,000 for the TAT approach. When presented with thyroid cancer, 20 % of all respondents still preferred TAT, even if it would not cure their disease. Patients preferring TAT over CerT were younger, female, more willing to accept complications and spend additional money, and, most significantly, preferred the TAT approach, even if it was less likely to cure their cancer.
Although this survey presents a hypothetical question for people who do not have thyroid disease, the majority of respondents preferred TAT over CerT. Furthermore, a substantial number were willing to accept higher complication rates and increased costs for TAT.
经腋窝甲状腺切除术(TAT)在东亚国家越来越受欢迎;然而,迄今为止,尚未有人尝试评估美国人群对TAT的偏好。本研究的目的是评估美国队列中与TAT相关的偏好和考虑因素。
在一个州的不同地点向966名成年人发放了自填式调查问卷。问题评估了对手术方式的偏好、可接受的风险和额外费用,以及尽管癌症治疗效果降低仍愿意接受TAT的意愿。
回复率为84%,平均年龄为40±17岁。大多数受访者为女性。在受访者中,82%在所有风险相同的情况下更喜欢TAT而非颈部甲状腺切除术(CerT);51%的受访者愿意接受TAT 4%的并发症发生率,16%表示他们愿意为TAT手术额外支付高达5000美元。当面对甲状腺癌时,20%的受访者仍然更喜欢TAT,即使它无法治愈他们的疾病。比起CerT更喜欢TAT的患者更年轻、为女性、更愿意接受并发症并花费额外的钱,最重要的是,即使TAT治愈癌症的可能性较小,他们也更喜欢这种手术方式。
尽管这项调查为没有甲状腺疾病的人提出了一个假设性问题,但大多数受访者更喜欢TAT而非CerT。此外,相当一部分人愿意接受TAT更高的并发症发生率和增加的费用。